Succinic Acid

Succinic Acid

SCHEMBL729634

O=C(O)CCC(=O)O.O=CCc1ccc(O)cc1

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1CDK4CDK6CHRM2CHRM3DPP4DRD2DRD3DRD4EGFRHRH1HTR1BHTR1DHTR1FHTR2AHTR2CHTR4SLC6A2SLC6A4

The experimentally established mechanism targets of Succinic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.56
CAMK2A Q9UQM7 1/20 0.56
CYP1A1 P04798 1/20 0.50
FNTA P49354 1/20 0.45
FNTB P49356 1/20 0.45
ESR1 P03372 3/20 0.44
ESR2 Q92731 3/20 0.44
ALDH1A1 P00352 1/20 0.44
CYP3A4 P08684 1/20 0.44
NAALAD2 Q9Y3Q0 1/20 0.42
SLC7A5 Q01650 1/20 0.42
FFAR1 O14842 1/20 0.42
TOP1 P11387 1/20 0.42
CTBP2 P56545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL105690 0.89 ESR1 (0.52) CA2CAMK2AFNTAFNTBESR1
SCHEMBL31422585 0.83 FFAR1 (0.63) CA2FFAR1
Parahydroxybenzyl Alcohol SCHEMBL27626310 0.80 CA2 (0.58) CA2CAMK2ACYP1A1FNTAFNTB
SCHEMBL21960079 0.77 TOP1 (0.73) CA2CAMK2AESR1ALDH1A1CYP3A4
Phenylacetaldehyde SCHEMBL27573996 0.77 CA1 (0.52) CA2FNTAFNTBTOP1
SCHEMBL3115195 0.77 CA2 (0.60) CA2CAMK2AALDH1A1FFAR1
Hydroxyphenyl Propionic Acid SCHEMBL35486 0.77 FFAR1 (0.68) CA2CAMK2AESR1ESR2ALDH1A1
Isobutyraldehyde SCHEMBL3923146 0.77 TAAR1 (0.45) CA2CAMK2AESR1ESR2
SCHEMBL2028391 0.77 CA2 (0.65) CA2CAMK2ACYP1A1FNTAFNTB
SCHEMBL4383010 0.77 ESR1 (0.58) ESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2361310-A2 BIOSYNTHESIS OF COMMODITY CHEMICALS Bio Architecture Lab, Inc. (US) 2011-08-31 EP claimed
US-20100185017-A1 BIOSYNTHESIS OF COMMODITY CHEMICALS BIO ARCHITECTURE LAB, INC. 2010-07-22 US claimed
WO-2010068921-A2 BIOSYNTHESIS OF COMMODITY CHEMICALS BIO ARCHITECTURE LAB, INC. (US) 2010-06-17 WO claimed
EP-2195440-A2 BIOFUEL PRODUCTION Bio Architecture Lab, Inc. (US) 2010-06-16 EP claimed
US-20090155873-A1 BIOFUEL PRODUCTION BIO ARCHITECTURE LAB, INC. (US) 2009-06-18 US claimed
US-20090139134-A1 BIOFUEL PRODUCTION BIO ARCHITECTURE LAB, INC. (US) 2009-06-04 US claimed
WO-2009046375-A2 BIOFUEL PRODUCTION BIO ARCHITECTURE LAB, INC. (US) 2009-04-09 WO claimed
WO-2009046370-A2 BIOFUEL PRODUCTION BIO ARCHITECTURE LAB, INC. (US) 2009-04-09 WO claimed
US-20130252312-A1 BIOFUEL PRODUCTION BIO ARCHITECTURE LAB, INC. (US) 2013-09-26 US disclosed
US-8318464-B2 Biofuel production BIO ARCHITECTURE LAB, INC. (US) 2012-11-27 US disclosed
US-8318473-B2 Biofuel production BIO ARCHITECTURE LAB, INC. (US) 2012-11-27 US disclosed
US-8211689-B2 Biofuel production BIO ARCHITECTURE LAB, INC. (US) 2012-07-03 US disclosed
US-8198056-B2 Biofuel production BIO ARCHITECTURE LAB, INC. (US) 2012-06-12 US disclosed
US-20120142081-A1 BIOSYNTHESIS OF COMMODITY CHEMICALS BIO ARCHITECTURE LAB, INC. (US) 2012-06-07 US disclosed
WO-2010068921-A2 BIOSYNTHESIS OF COMMODITY CHEMICALS BIO ARCHITECTURE LAB, INC. (US) 2010-06-17 WO disclosed
EP-2195440-A2 BIOFUEL PRODUCTION Bio Architecture Lab, Inc. (US) 2010-06-16 EP disclosed
US-20090155873-A1 BIOFUEL PRODUCTION BIO ARCHITECTURE LAB, INC. (US) 2009-06-18 US disclosed
US-20090139134-A1 BIOFUEL PRODUCTION BIO ARCHITECTURE LAB, INC. (US) 2009-06-04 US disclosed
WO-2009046375-A2 BIOFUEL PRODUCTION BIO ARCHITECTURE LAB, INC. (US) 2009-04-09 WO disclosed
WO-2009046370-A2 BIOFUEL PRODUCTION BIO ARCHITECTURE LAB, INC. (US) 2009-04-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100185017-A1 BIOSYNTHESIS OF COMMODITY CHEMICALS COASY, HSD17B14, FASN CA2 3762/4885CAMK2A 3733/4885CYP1A1 63/4885
US-20090139134-A1 BIOFUEL PRODUCTION MGAM, DCXR, MANBA CA2 3146/4885CAMK2A 4018/4885CYP1A1 148/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.